% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

jetmanbash 426 posts  |  Last Activity: 6 hours ago Member since: Dec 29, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • jetmanbash jetmanbash 6 hours ago Flag

    I don't think trying to lie to people and recommend an investment that lost over 89% of its value is helping anyone. The chums are a jealous bunch but their Voo-Doo has worked magic for ISIS. With the huge amount of money that ISIS shareholders have they will be able to donate to the charity of their choice. If one of the chums donates one share of vicl a child could receive a Popsicle. So in your own way you've shown others the right way and that is to invest in ISIS so I thank you for that. They've seen the lying about the $200 per share for ISIS and other lies. This has helped the unbiased investor make their way to ISIS. Again thank you. Please if you do resort to commune living please leave an mailing address and some of us may make a donation to the commune. t

  • Reply to

    it seems to me,,,,

    by bcpiii Mar 28, 2015 8:35 AM
    jetmanbash jetmanbash 7 hours ago Flag

    You are speculating that people who try and trade will do well. How about like on the CNBC commercial you give everyone a $100 K to trade for you and like that guy in the commercial we get to keep 60%.......I would bet that the average trader even trying with your money would lose everything. You are giving the most extreme in danger as far as encouraging trading. The little meek RNN could inherit the CA earth. The traders will all be long gone. t

  • Reply to

    Good Rally in the Market, RNN?

    by topgeardel 11 hours ago
    jetmanbash jetmanbash 7 hours ago Flag

    You stated what you had to say for maybe the 100th time. I think you are jealous and don't want anyone to be successful. Also, it is a well known fact that the average "successful" trader sits over a hot screen all day and makes about $350 bucks. t

  • jetmanbash jetmanbash 7 hours ago Flag

    You are looking bad dude. I don't know you like the rest of the chums. Any one can look up that vicl hit over $59 in the year 2000. ISIS has never hit $200 and it's high was just a month ago. All of the chums have pumped vicl so again that is not truth. Any prediction for vicl has been an on-going thing for well over four years. In fact sour and some of the chums were predicting when vicl would pass ISIS in price......never happened. If Cramer or anyone would say something bad about ISIS you'd be right there. How don't know how long long term visionary is, but so far since the year 2000 vicl has had a long term vision that can be followed via a chart down from 59 to less than a buck. What is interesting about that is the best news vicl can dig up is to buy a fungal drug cast-off from Astellas. A drug that is completely away from their core that they have no experience in. OGXI no matter what you say about still goes for more than vicl and has more going for it than vicl. Their problem is that they are not the Tower of Power like ISIS is. Their technological platform is behind ISIS by about six years........But everyone in vaccines is ahead of vicl. I suggest you look at the last sentence you wrote too. Astellas may have fed vicl pxx-pxx with their sale to vulnerable vicl. Thank you again though for the reverse Voo-Doo to help ISIS we'll talk plenty over the next six months. Please get those heavy duty undies on for your spankings too. Thanks again. t

  • jetmanbash jetmanbash 12 hours ago Flag

    "Dude" I think you could be alittle mistaken. If Astellas wanted vicl they would have bought them already......unless of course they think that they are going down further. More likely Astella used vicl as a burying ground for that antifungal drug, or that the very least the de-risked their situation by passing it off to a very weak player with no experience in that field. You have my vote to drive the Italian cruise liner of biotech vicl. Good luck to you. t

  • jetmanbash jetmanbash 15 hours ago Flag

    You guys own a lot of vicl already. Why don't you and the chums just buyout vicl and insert "the dude" as CEO?? t

  • jetmanbash jetmanbash 16 hours ago Flag

    Big I know you always struggled in math class and wanted to go to college and couldn't, so you get a get out of jail card for free for life based on your situation. Please obtain those double underalls for protection over the next few months for the spankings, and soiling that you will have take place. Good luck to you though. t

  • For a med that treats Huntington's Disease symptoms. Makes one wonder the value of ACAD's drug? t

  • ISIS drug for Huntington's Disease is the only drug to really hit the disease directly. So whatever TEVA is over $100 bucks per share for a company with less than four drugs, ISIS Huntington's Disease drug is probably worth more. t

  • Reply to

    it seems to me,,,,

    by bcpiii Mar 28, 2015 8:35 AM
    jetmanbash jetmanbash Mar 29, 2015 8:14 PM Flag

    Thanks Dad, can I borrow the car now?! t

  • Reply to

    Why Darkster is right again

    by vicl_dude Mar 29, 2015 3:09 PM
    jetmanbash jetmanbash Mar 29, 2015 8:12 PM Flag

    This dude the answer is number 6, None of the above!! t

  • Reply to

    ACAD mentioned in MotleyFool article.

    by crecy_war_knight Mar 29, 2015 10:30 AM
    jetmanbash jetmanbash Mar 29, 2015 3:21 PM Flag

    CLDN is going to have competition in regards to their heart failure drug. I know you didn't post this link based on that, but if someone is pursuing them they should know that NVS has their heart failure drug as does MSTX. The drug from MSTX isn't a permanent fix but their data looks very intriguing and with stem cell technology you are talking huge costs. Thus CLDN might put themselves in a GILD type of situation.....that being trying to charge huge prices for a drug that treats the masses, definitely not an orphan drug space. t

  • jetmanbash jetmanbash Mar 29, 2015 2:43 PM Flag

    The chums will be able ot survive. The vicl stock certificates could be made into a variety of survival substances. I heard that they even have a patent to make Hall's Cough Drops out of them.....Just a hint, don't buy any cough drops from any dollar store. t

  • jetmanbash jetmanbash Mar 29, 2015 12:37 PM Flag

    Big, when you and the chums draw up your squak box agenda you all come out with the same thing/same person so that does apply to you. That's OK because the $200 per share thing is coming and I'm going to give you credit for predicting it as well as the dude or kid. t

  • Reply to

    it seems to me,,,,

    by bcpiii Mar 28, 2015 8:35 AM
    jetmanbash jetmanbash Mar 29, 2015 11:28 AM Flag

    A vary wide therapeutic index like this bcp could put a drug like this into hyperspace and it could quickly become the drug of choice for its approved indications. The reason why PCYC did so good with their one drug was two things. It was a pipeline in a drug, and it especially gentle on older patients with blood CA's as a second line therapy and at times a first line therapy. This drug RX-3117 could fit that same least it seems that way. Take care, t

  • Reply to

    Why I like Vical more than isis

    by vicl_dude Mar 28, 2015 11:25 AM
    jetmanbash jetmanbash Mar 29, 2015 10:33 AM Flag

    Only your number 2 is correct. t

  • jetmanbash jetmanbash Mar 29, 2015 12:20 AM Flag

    Hi Big, IDRA is an ANS company that also has a platform in TLR's. They have received advice and help from ISIS in the past. Just so when the chums do the reverse vodoo chant to help ISIS out you need to remember that ISIS was never $200 a share.....but it will be. Also, you are requesting patience and forgiveness for the sloppy performance of the A-7 vecfticion and you are riding ISIS so-called past performance?! RNN will surpass vicl before the year is over, but please don't go silent. There are special thickened underwear that you may want to purchase with the holding of the vj run company with that dying technology and the new med that will be sucking up resources. Good luck Big. t

  • Reply to

    Someone with Spinal Muscular Atrophy

    by colinelbasani Mar 28, 2015 10:38 PM
    jetmanbash jetmanbash Mar 29, 2015 12:13 AM Flag

    Are you sure that the diagnosis is correct? That doesn't sound like a SMA type patient to me. Maybe Becker's MD? In any case if he did have it, it would have to fall into like Type4 and JMO, but I don't think that there would be any help from this drug for that patient profile. t

  • Reply to

    it seems to me,,,,

    by bcpiii Mar 28, 2015 8:35 AM
    jetmanbash jetmanbash Mar 28, 2015 11:07 PM Flag

    The super angle on what you brought up bcp is if RX-3117 can "rescue" Gemzar and really make it allow patients that have become resistant to it regain sensitivity in treating patients for cancers, particularly pancreatic CA. If you couple that with two drugs showing a synergistic effect in treating CA, and a big IF, if LLY goes with and is able to use RNN's technology for delivery of older CA drugs to the target area in a more efficient manor so as to turn Gemzar into a propitiatory drug again. If this scenario alone takes place we'll all be doing very well from an investment standpoint on just this alone. I rate this as a better than 50/50 chance based on what we continue to see in regards to their clinical work. t

  • Based on their convoluted methods it is important to know that they really want ISIS to go higher. They however lack the ability to do so besides what they have done already. They want to bad mouth the stock to really make sure you want to own it and then they want to wish the stock well by their offerings up to the prune juice gods. But that is where they have to stop because they don't really know too much about what has transpired in regards to ISIS over the last ten years. ISIS has become a real force in the biotech world and I believe that will become more known over the next six months. So I want to thank the chums for their limited ability to help ISIS surge higher but tell everyone that they don't have access to the latest developments in regards to ISIS. I will report here after the annual meeting all of the latest ISIS developments so that you can follow your investment more closely than what the chums can offer, God bless them, but they also are fighting to keep themselves from going BK due to their religious duties to vicl. So pray for them, and follow the latest ISIS advancements as they progress here. t

64.81+1.44(+2.27%)Mar 30 4:00 PMEDT